InsidersTradesSigma
Follow the Ascelia Pharma AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Ascelia Pharma AB has logged 9 reports. Market capitalisation: €65.6m. The latest transaction was reported on 26 November 2025 (Purchase). Among the most active insiders: Peter Benson. The full history is free.
9
Insider Decl.
n/a
Thresholds
€4,840
3 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Ascelia Pharma AB Strong Buy (bullish), based on 3 analysts. Average price target: SEK 2.87.
36Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 November 2025
Declarations9 total
24,975 shares0AktieISIN SE0010573113FI:A003U165-1
1,754 shares0AktieISIN SE0010573113FI:A003U157-1
15,000 shares@ €0.32270.0012% mcap100.0% of flowAktieISIN SE0010573113FI:A003S559-1
6,152 shares@ €0.19270.0003% mcap22.1% of flowAktieISIN SE0010573113FI:A003N440-1
21,688 shares@ €0.19270.0011% mcap77.9% of flowWarrantISIN SE0022725438FI:A003N439-1
10,000 shares@ €0.19270.0005% mcap100.0% of flowAktieISIN SE0010573113FI:A003N414-1
100,000 shares@ €0.19270.0049% mcap100.0% of flowAktieISIN SE0010573113FI:A003N410-1
112,500 shares0AktieISIN SE0010573113FI:A001P652-2
539,685 shares0AktieISIN SE0010573113FI:A001P626-2
9 of 9 declarations
About Ascelia Pharma AB
Ascelia Pharma AB is a biopharmaceutical company focused on developing treatments for health-related diseases. It is listed on the Stockholm Stock Exchange (XSTO).